Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Grant/Award of 31,667 AUTL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Autolus Therapeutics plc (AUTL) | Grant/Award | 31,667 | n/a |
| Jun 29, 2026 | IMMUNIC, INC. (IMUX) | Grant/Award | 100,000 | n/a |
| Aug 19, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 11,250 | $789.8K |
| May 19, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 11,250 | $1.48M |
| May 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 775 | n/a |
| May 20, 2024 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 5,228 | n/a |
| Dec 29, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 30,000 | $2.89M |
| Aug 4, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 22,477 | n/a |
| May 19, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,454 | n/a |
| Aug 3, 2021 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 22,477 | n/a |